VolitionRx Limited
VNRX · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,234 | $775 | $306 | $90 |
| % Growth | 59.1% | 153% | 240.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1,234 | $775 | $306 | $90 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $14,406 | $19,552 | $15,333 | $13,022 |
| G&A Expenses | $12,717 | $15,907 | $15,351 | $14,080 |
| SG&A Expenses | $13,640 | $16,919 | $16,405 | $14,826 |
| Sales & Mktg Exp. | $923 | $1,013 | $1,054 | $746 |
| Other Operating Expenses | $212 | $292 | $349 | $574 |
| Operating Expenses | $28,258 | $36,763 | $32,086 | $28,423 |
| Operating Income | -$27,025 | -$35,988 | -$31,780 | -$28,333 |
| % Margin | -2,190.9% | -4,641.8% | -10,372.4% | -31,469% |
| Other Income/Exp. Net | -$233 | $311 | $1,182 | $1,343 |
| Pre-Tax Income | -$27,258 | -$35,677 | -$30,598 | -$26,990 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$26,968 | -$35,319 | -$30,269 | -$26,815 |
| % Margin | -2,186.3% | -4,555.5% | -9,879.1% | -29,782.5% |
| EPS | -0.31 | -0.5 | -0.55 | -0.51 |
| % Growth | 38% | 9.1% | -7.8% | – |
| EPS Diluted | -0.31 | -0.5 | -0.55 | -0.51 |
| Weighted Avg Shares Out | 86,531 | 71,235 | 55,350 | 52,656 |
| Weighted Avg Shares Out Dil | 86,531 | 71,235 | 55,350 | 52,656 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $93 | $125 | $3 |
| Interest Expense | $340 | $222 | $173 | $156 |
| Depreciation & Amortization | $1,339 | $1,413 | $1,190 | $1,145 |
| EBITDA | -$25,579 | -$34,042 | -$29,235 | -$25,689 |
| % Margin | -2,073.6% | -4,390.8% | -9,541.8% | -28,532% |